MiMedx Group Inc
MDXG
$4.43-5.34%
End of day · as of Oct 17, 2026, 3:30 AM ET
Mkt cap
$537.69M
EV/Sales
0.93
P/E ratio
N/A
FY2025 Revenue
$418.63M
EPS (TTM)
$0.04
Gross Margin (FY2025)
82.56%
Profit Margin (FY2025)
11.60%
Beta
1.46
Div yield
N/A
Sector
Healthcare
MiMedx Group Inc (MDXG) is a biotechnology company listed on US.
Latest reported MDXG revenue for 2025-12-31 was $418.6M. Net income was $48.6M. Revenue was up 20.0% from 2024-12-31 to 2025-12-31. MDXG currently screens at market cap $537.7M.
Use this MDXG research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MDXG income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
MiMedx Group Inc (MDXG) is a biotechnology company in the Healthcare sector.
Latest cached MiMedx Group Inc (MDXG) revenue for Dec 31, 2025 was $418.6M. Net income was $48.6M. Statements: https://lician.com/financials/mdxg
MiMedx Group Inc (MDXG) market capitalization is $537.7M on the latest cached snapshot.
MiMedx Group Inc (MDXG) cached previous close $4.68; day range $4.43 – $4.66; volume 2,564,337. Session quote: https://lician.com/quote/mdxg
MiMedx Group Inc (MDXG) latest cached earnings event is "MDXG earnings" on Jul 29, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MDXG filing is 8-K · Oct 16, 2026. Filings: https://lician.com/sec/mdxg